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Recently, several laboratories have derived monoclonal antibodies (mAb) 1 that 
react with clonotypic determinants of the heterodimeric antigen receptor mole- 
cules expressed on human (1-6) and murine T  cells (7-12).  In some instances 
these antibodies (also referred to as anti-Ti) mimic the effect of specific antigens 
by inducing proliferation of and lymphokine release by T lymphocytes  expressing 
the corresponding clonotype (1,  4,  13).  On  the other hand, antibodies to  the 
monomorphic T3  molecules are also able  to  induce T  cell  proliferation  and 
lymphokine release, but  this  effect is not clonotypically restricted (13-14).  In 
addition, soluble anti-T3 antibody blocks antigen-induced specific T  cell stimu- 
lation (13) as well as specific target cell lysis by cytolytic T  lymphocytes (15-19). 
The  effects  of anti-T3  antibody  have  been  explained  by  the  fact  that  T3 
molecules are  physically and  functionally  linked  to  the  Ti-bearing  receptor 
molecules (20). Recently (21, 22), however, some antibodies directed against the 
T11  molecule, which is physically unrelated to the Ti-T3  complex, have also 
been  shown  to  activate  T  cells  leading  to  cell  proliferation  and  lymphokine 
release.  In the present study we have analyzed a  third nonclonotypic molecule 
(designated T44) that appears to be involved in human T  cell activation. T44 
has been recently defined by the 9.3 mAb as a T-specific (23) surface glycoprotein 
of approximately Mr 44,000  (44  K) (24).  The 9.3 antibody has been reported 
(25) to enhance the proliferative responses to phytohemagglutinin or to alloge- 
neic cells, but to have no effect on resting T  lymphocytes. Here we show that 
the 9.3  (anti-T44) mAb, in the presence of adherent cells, can directly induce 
human peripheral blood T  lymphocytes to proliferate and release interleukin 2 
(IL-2). The availability of a  variant of the 1L-2-produc!ng Jurkat leukemia cell 
line (termed JA3), and of four corresponding anticlonotypic antibodies, allowed 
a better analysis of the molecular and functional characteristics of this molecule 
and its  relationship with  Ti,  T3,  and T11  structures.  Thus,  upon  interaction 
with the anti-T44  mAb, T44  molecules underwent rapid modulation from the 
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JA3  cell  surface;  moreover,  neither  T3,  T11,  nor  clonotypic  molecules  co- 
modulated with T44.  Modulation  of T3  or Ti structures  by the corresponding 
antibodies,  although  not  affecting T44  antigen  expression,  did  abrogate  IL-2 
production  in  response  to  anti-T44  antibody.  In  contrast,  modulation  of T44 
antigen had no effect on IL-2 production elicited by anti-T3 or anti-Ti antibodies. 
Thus, T44  may be part of an antigen-independent  pathway of T  cell activation 
that is not physically linked to the T3-Ti receptor complex or the T11  molecule. 
Materials and  Methods 
Cells.  Mononuclear cells (MNC) were isolated from human peripheral blood (PB) and 
adherent cells removed by incubation on plastic petri dishes. Purified T  cells were isolated 
from PBMNC by rosetting with sheep erythrocytes as previously described (26).  Mixed 
leukocyte  culture  (MLC)-activated  T  cell  populations  were  obtained  by  stimulating 
PBMNC (106 per well) with irradiated (5,000 rad) human allogeneic spleen cells (106 per 
well) as described (27). On day 7, cells were harvested and centrifuged on Ficoll-Hypaque 
gradients,  to remove dead cells.  Human thymuses (age,  I-8 yr) were removed during 
corrective cardiac surgery and  used as a  source of thymocytes, as previously described 
(28). TheJA3 cloned cell line was derived by mutagenesis from the IL-2-producingJurkat 
T-ALL by exposing these cells  to 200 rad gamma radiation (cesium source). Cells were 
then  selected on  the  basis of their resistancy to 6-thioguanine (hypoxanthine guanine- 
phosphoribosyltransferase-deficient mutants) containing medium. This selection was per- 
formed six times over a period of 40 d. Selected microcultures containing cells resistant 
to 6-thioguanine were cloned and tested for both IL-2 production and expression of T3 
antigen. JA3 was selected because it was the clone that displayed the highest levels of IL- 
2  production  and  also expressed large  amounts of T3  antigen  as assessed by indirect 
immunofluorescence. 
Monoclonal  Antibodies.  The UCHT1  mAb (29) (directed to surface T3 antigen) was 
kindly provided by Dr.  M. J.  Crumpton  and  Dr.  P.  C.  L.  Beverley (Imperial Cancer 
Research Fund,  London). The 4F2 and 3A1  mAb (30) were a generous gift of Dr. A. S. 
Fauci  (National  Institutes of Health,  Bethesda,  MD).  Leu-4 mAb was purchased from 
Becton,  Dickinson  &  Co.,  Basel,  Switzerland,  and  the  9.3  (NEI-ol2) mAb from  New 
England Nuclear, Dreieich,  Federal  Republic of Germany. mAb with specificity for the 
antigen receptor-like molecule expressed on JA3 cells were derived from a fusion between 
the P3-U1  mouse myeloma cell line and spleen cells  from BALB/c mice that had been 
immunized intravenousl~ with 107 JA3 cells in phosphate-buffered saline (PBS). A booster 
injection with  1.5  ×  10"JA3  cells was performed  15 d  later, and immune splenocytes 
were fused with P3-U 1 myeloma cells 3 d after the injection, as described (31).  Screening 
of the hybridomas was based on the capacity of the various hybridoma supernatants to 
induce IL-2 production by JA3 in the presence of phorbol myristate acetate (PMA). Four 
different hybrids were isolated for further characterization, as described in more detail 
elsewhere  (Moretta,  A.,  G.  Pantaleo,  M.  Lopez-Botet, and  L.  Moretta,  submitted  for 
publication). These four hybrids, proved to be specifically reactive with the immunizing 
~5  JA3 cells and to immunoprecipitate from  I-labeled JA3  cells a protein with a diffuse 
band  of  80-85  kD  (nonreduced).  Under  reducing  conditions,  this  protein  could  be 
resolved into two major peptides of 40 and 45 kD. The four mAb were termed JTi~, JTi~, 
JTi3, and JTi4, respectively. 
Characterization  of Radioiodinated  Cell Surface Proteins.  JA3 ceils were surface labeled 
with ~z~I using lactoperoxidase-glucose-oxidase-catalyzed iodination (32).  ~30 ×  106 cells 
were washed and resuspended in 1 ml PBS containing glucose (5.5 mM) and the following 
reagents: 20 #1 KI (5 ×  10 -5 M), Na125I (1  mCi), 40 #l lactoperoxidase (1  mg/ml solution 
in PBS),  10 #i glucose oxidase (stock solution diluted  1:100 in PBS). Cells were incubated 
at 4°C.  After  10 and  20 min,  10 #1 glucose oxidase was added and the incubation  was 
carried out for a total period of 30 min. Cells were then washed five times in cold RPMI 
1640,  twice in  PBS,  and  lysed in  10  mM Tris-buffered saline  (pH  7.5)  containing  1% MORETTA  ET  AL.  825 
Nonidet P-40 (NP-40),  i  mg/ml bovine serum albumin, and 0.1  mM phenylmethylsul- 
phonyl fluoride (PMSF), for 90 min at 4°C. After spinning at 100,000 g, the supernatant 
was then immunoprecipitated as follows. Supernatants were dialyzed with PBS containing 
0.05%  NP-40  and  0.1  mM  PMSF and  precleared  three  times  with  100  #1  of packed 
protein A-Sepharose beads for 2 h under rotation. Aliquots (900 ~1) were then incubated 
for 2 h with 20 ~1 of a  1:10 dilution of anti-T44 (9.3) mAb or 10 #1 of anti-Ti (JTi4) ascite 
diluted 1:50.20 #1 of protein A-Sepharose beads were then added and samples incubated 
for 4 h at 4°C. The immunoprecipitate was eluted from protein A-Sepharose by boiling 
for  2  min  in  5%  sodium  dodecyl sulfate  (SDS)  in  the  presence  or absence of 5%  2- 
mercaptoethanol and analyzed on 11% discontinuous SDS-polyacrylamide gels (33). 
For absorption studies, after incubation with the packed anti-T44 (or anti-JTi4) mAb- 
specific immunoabsorbent, the cell lysate was reincubated twice with the same immunoab- 
sorbent, following the procedure described above. Using this protocol, virtually complete 
depletion  of the  corresponding  T44  (or JTi)  molecules  was  achieved.  The  resulting 
"cleared"  cell  lysate was  then  incubated  with  the  anti-JTi (or anti-T44)  mAb-specific 
immunoabsorbent for an additional 3 h at 4 ° C. After washing, the specific bound material 
was eluted and separated by SDS-PAGE as described above. 
Flow Cytofluorometric  Analysis.  The  techniques  used  have  been  described  in  detail 
elsewhere (34). Briefly, aliquots of 105 cells (peripheral lymphocytes, MLC-induced blast 
cells,  thymocytes,  or JA3  cells)  were  stained  with  the  appropriate  mAb  followed  by 
fluoresceinated goat anti-mouse Ig. Control aliquots were stained with the fluorescent 
reagent alone.  All  samples were then analyzed on a  flow cytometer (FACS  II; Becton 
Dickinson Immunocytometry Systems, Mountain View, CA) gated to exclude nonviable 
cells. Results are expressed as arbitrarily normalized fluorescence histograms, i.e., number 
of cells vs. fluorescence intensity. 
Proliferation  of PB  T  Lymphocytes  in  Response  to  mAb  or  Phytohemagglutinin  (PHA). 
Proliferative responses of PB T  lymphocytes to mAb or PHA were analyzed as follows. T 
lymphocytes (or unfractionated  PBMNC) were cultured as described elsewhere (31)  in 
triplicate  microwells (105  cells/well)  (Greiner  Labor Technik,  Nurtinger,  FRG)  either 
alone or with  1-2  ×  104 adherent cells in 0.2  ml with  RPMI  1640  supplemented with 
10% fetal calf serum (FCS) (Gibco Laboratories, Grand Island, NY), L-glutamine, penicil- 
lin-streptomycin, and one or another stimulus,  for varying culture  intervals.  PHA was 
used at a final dilution of 1:100.  mAb were used at the following dilutions:  Leu-4 mAb, 
1:100 to 1:1000 of the stock solution; 9.3 mAb, 1:40 to 1:500 of the stock solution; 3A 1, 
4F2, and U CHT 1 mAb, i:i 000 dilution of ascitis. After incubation at 37 °C in a 6% COs, 
humidified atmosphere for different culture intervals, individual wells  were pulsed with 
1 #Ci  of [SH]thymidirre ([SH]TdR) (Amersham  U.K)  16-18  h  before harvesting.  Each 
value represents the mean of triplicate cultures. Standard deviations were <10%. 
Determination  of IL-2 Production by Peripheral T Lymphocytes.  To evaluate the amount 
of IL-2 produced by lymphocytes after stimulation with lectin or mAb, we used a murine 
T  cell proliferation assay as described (35).  Briefly, peripheral blood lymphocytes (105) 
were cultured for varying periods of time in the presence of one or another stimulus (see 
above) under the same culture conditions mentioned above. In experiments performed 
to study the effect of modulation of T3 or T44 antigens on the subsequent antibody- 
induced  IL-2 production,  "modulated" or "unmodulated" purified T  lymphocytes were 
cultured (105 per well)  in the presence of mAb and  104 adherent cells for 48 h  before 
collection of culture  supernatants.  100  #1  of culture  supernatants  were removed from 
each microculture and added at a final concentration of 50% to 4 x  105 murine indicator 
cells (CTLL line,  kindly provided by Dr.  K. Smith [36]).  IL-2 activity was assessed by 
[5H]TdR uptake by CTLL after a 6 h pulse with  1 #Ci of [3H]TdR at the end of a 24 h 
culture period. 
Determination  oflL-2 Production byJA3.  To quantitate the amount of IL-2 secreted by 
JA3  cells after stimulation with  mitogen or mAb, JA3  cells (1.5  ×  105 per well)  were 
cultured in the presence of phorbol myristate acetate (PMA) (10 ng/ml) or 104 adherent 
cells and one or another stimulus for a  24 h  period. Thereafter,  100 #l of supernatant 
were  removed and  assessed  for  IL-2  activity on  the  murine  CTL  line,  as  previously 826  ANTIGEN-INDEPENDENT  PATHWAY  OF  T  CELL  ACTIVATION 
described (35).  PHA was used at a final dilution of 1:100; Leu-4 and 9.3 mAb, 1:200 to 
1:500; 3A1  and 4F2 mAb,  1:t000 dilution of ascitis;  UCHT-1 mAb,  1:5000 dilution of 
ascitis; JTi] and JTi4 mAb, 1  : 10 dilution of the hybridoma culture supernatant. 
Modulation Experiments.  Antigenic  modulation  of JA3  cells  or purified  T  cells  was 
performed by addition  of one or another mAb and incubation for 24 h at 37°C in  6% 
CO2.  To ensure that modulation was performed in the presence of a saturating amount 
of mAb, a  large antibody excess was  used.  Cells  were cultured  in  flat-bottomed wells 
(Costar, Data Packaging, Cambridge, MA) at a concentration of 106/ml in  RPMI  1640 
(Seromed, Biochrom, FRG),  10% FCS, with the following final dilutions of mAb: Leu-4 
and 9.3,  1:100 of the stock solution; 3A1, MAR 206 (anti-T11), 4F2, UCHT1 (anti-T3), 
JTi], and JTi~ mAb,  1:100 of the ascitic fluid. After modulation at 37°C for 24 h, cells 
were  harvested,  washed  twice,  and  either  stained  directly with  fluorescent anti-mouse 
antibodies or incubated with one or another mAb followed by the fluorescent anti-mouse 
reagent (17).  The percentage of modulation as well as the percentage of reexpression of 
the various surface molecules was calculated according to Reinherz et al. (37).  The same 
experimental procedure was used in experiments in which cells were stimulated with mAb 
and PMA (or adherent cells) after antigen modulation (see above). 
Results 
Functional  Consequences of T44  Triggering  of Peripheral  Blood T Lymphocytes: 
Induction  of Cell Proliferation and IL-2 Release.  Prior studies (25) indicated  that 
anti-T44 antibody specifically reacted with human T  lmphocytes and enhanced 
the proliferative responses to PHA or to allogeneic cells, whereas no effect was 
observed on  unstimulated  lymphocytes.  In  view of the  potential  importance of 
T44 molecules in T  cell activation, we investigated the ability of anti-T44  mAb 
to  induce  lymphocyte  proliferation,  in  comparison  with  anti-T3  antibody  or 
PHA.  First,  the distribution  of T44 antigen  in  different T  cell populations was 
investigated.  Fig.  1 shows the reactivity pattern of anti-T44 or anti-T3 antibody 
with  peripheral  blood  lymphocytes,  thymocytes,  and  T  cells  activated  in  7-d 
MLC.  In adherent cell-depleted  peripheral  blood lymphocytes, a  large propor- 
tion of cells (65-75%) was T44 positive. In addition, the fluorescence distribution 
was clearly  bimodal  (Fig.  1 A),  similar  to  that  observed  with  anti-T3  antibody 
(Fig.  1D).  In  addition,  sequential  staining  with  anti-T44  and  anti-T3  antibody 
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FIGURE  I.  Fluorescence distribution of 1"44 (A-C)  and T3 (D-F)  antigen in peripheral blood 
unfractionated lymphocytes, MLC-activated T  cells, and thymocytes. The various cell popu- 
lations were stained with either 9.3 or UCHTI  mAb, followed by fluoresceinated anti-mouse 
Ig. Samples were run on a  FACS II, gated to exclude nonviable cells. MORETTA  ET  AL.  827 
(and vice versa) did not lead to any increase in the percentages of stained cells, 
indicating that T44 and T3 antigen were largely, if not totally, expressed by the 
same cells. Virtually  100% of T  cells activated in 7-d mixed lymphocyte culture 
expressed both T44 and  T3 antigen  (Fig.  1, B and E).  In contrast, only minor 
subsets  of  thymocytes  expressed  T44  or  T3  antigen  (C  and  F).  In  several 
experiments, the percentages of T44 + thymocytes were 10-20%. 
mAb directed to T3  molecules have been shown (21) to promote polyclonal 
proliferation of resting T  lymphocytes provided that monocytes are present in 
the  culture  assay.  The  mitogenic  potential  of anti-T44  mAb  under  culture 
conditions  giving  optimal  responses  to anti-T3  was  then  examined.  The anti° 
T44 mAb was compared with PHA and anti-T3 and 3-A1  mAb for the capacity 
to induce proliferation of peripheral  blood T  cells in the presence of 10-20% 
adherent  cells.  As  shown  in  Fig.  2A,  anti-T44  mAb  had  a  strong  mitogenic 
effect, comparable in magnitude to that obtained with anti-T3 antibody or PHA. 
However, unlike T  cell proliferation with  PHA or anti-T3  mAb,  that  induced 
by 9.3 mAb was maximal at day 5 of culture instead of day 3. Like anti-T3, anti- 
T44 antibody required macrophages  to mediate this mitogenic effect. Compa- 
rable results were obtained with  10 other donors (data not shown). The efficient 
T  cell proliferation obtained with anti-T44 antibody could be mediated via IL-2 
production by the responding T  cell populations.  To determine whether anti- 
T44 antibody was indeed capable of inducing IL-2 release, the same cell culture 
combinations  analyzed  in  proliferation  assays  were  tested  for IL-2  release.  In 
these experiments, culture supernatants were collected at different intervals and 
analyzed for IL-2 activity by a  proliferation assay,  using  the CTLL cells as an 
indicator system (36). Anti-T44 antibody did induce IL-2 production (Fig.  2B), 
as did  PHA  or anti-T3.  Note,  however, that  while  IL-2 activity with  PHA  or 
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FIGURE 2.  Anti-T44 antibody induces human peripheral blood T lymphocytes  to proliferate 
(A) and release IL-2 (B). Purified T  lymphoc~tes to which 10-20% adherent cells had been 
added (or simply PBMNC) were cultured (10  cells  per well) for different intervals with one 
of the following reagents: (e) 9.3 (anti-T44), final concentration 1:100 of the stock solution; 
(A) UCHT1  (anti-T3), 1:1000 of ascitic fluid; (H) 3A1, 1:1000 of ascitic fluid; (©) mAb or 
PHA. Cell proliferation was evaluated by [SH]TdR uptake (16 h pulse), whereas IL-2 produc- 
tion was assessed by adding culture supernatant to a standard 24 h proliferation assay using 
the IL-2-responsive  CTL indicator cells. In A, the proliferative responses of T cells alone (i.e., 
in the absence of adherent cells) to UCHT1 (&-.-&) or 9.3. (0" "Q) mAb are also shown. 828  ANTIGEN-INDEPENDENT  PATHWAY  OF  T  CELL  ACTIVATION 
anti-T3  was maximal  at  24 h,  it peaked at 48 h  in cultures  induced with anti- 
T44. 
Derivation  of ClonotypicaUy Restricted Antibodies Stimulating IL-2 Production from 
the T44-positiveJA3 Cell Line.  Analysis of the physical and functional relationship 
between T44 molecule and other surface molecules involved in T  cell activation, 
including  the  clonotypically  restricted  Ti  and  the  monomorphic  T3  or  T11 
molecules, required the availability of an appropriate IL-2-producing T  cell clone 
or tumor T  cell line and anticlonotypic antibodies selectively reactive with such 
cells. We recently derived by mutagenesis a variant of the Jurkat leukemic T  cell 
line,  designated JA3  (surface  phenotype:  Tll ÷,  T3 +,  3A1 +,  T4-,  T8-,  DR-, 
TAC-,  4F2  +,  T44+),  which  produces  large  amounts  of IL-2  upon  stimulation 
with PHA or with anti-T3  mAb in conjunction with PMA or adherent cells. To 
produce mAb against clonotypic structures of JA3  cells, we used these cells to 
immunize BALB/c mice. Subsequently, immune splenocytes were fused with P3- 
U1  mouse myeloma line by standard  hybridization  techniques.  Supernatants  of 
the 372 individual hybridomas were screened according to their ability to induce 
JA3 to produce IL-2 in the presence of PMA. By this screening procedure, we 
selected four stimulatory mAb that reacted with JA3 but lacked reactivity with 
any other T  tumor cell line tested, with resting or activated T  cell populations 
and several T  cell clones, as assessed by indirect immunofluorescence on a FACS. 
These antibodies were termed anti-JTil,  -JTi2, -JTi3, and -JTi4 and were of the 
IgG2a (JTil_3)  and  IgG2b (JTi4) murine  isotype, respectively. JTil_4 antibodies 
were  shown  to  immunoprecipitate  in  SDS-polyacrylamide  gel  electrophoresis 
(SDS-PAGE) a single diffuse band of 85 K Mr under nonreducing conditions and 
two major peptides of Mr 40 and 45 K under reducing conditions (see below). In 
some experiments,  however, a  third  band  could be visualized  under  reducing 
conditions.  In this respect it should be noted that anti-Ti  mAb directed against 
T  cell clones (1),  T  cell  lines such as  REX  (38) or HPB-ALL (2,  5),  or T  cell 
leukemias (3,  4) usually precipitate  only two bands under  reducing conditions. 
However, our results are in line with the data reported by Weiss and Stobo (6), 
who used an  anti-Ti  mAb directed against  a  nonmutagenized Jurkat  clone.  In 
addition,  cross-inhibition  and sequential immunoprecipitation  experiments pro- 
vided clear evidence that anti-JTil_4 reacted with the same surface molecule on 
JA3 cells. The  reactivity pattern  of the antibodies,  their  functional  properties, 
and the characteristics of the immunoprecipitated molecules clearly indicate that 
JTij_4 recognize cionotypic determinants of the T  cell receptor molecule. While 
further characteristics of JTil_4 antibodies have been described elsewhere (Mor- 
etta, Pantaleo,  Lopez-Botet, and Moretta, submitted for publication),  here such 
anticlonotypic  antibodies  were  used  as a  tool  for  analysis  of the  physical  and 
functional  relationship  between T44  molecules and the T3-Ti  molecular com- 
plex. 
Anti-T44 Antibody Immunoprecipitates  a Prevalent Mr 80 K Band Under Nonre- 
ducing Conditions.  The molecule immunoprecipitated  by the 9.3 antibody was 
originally termed T44 on the basis of the apparent Mr under reducing conditions 
(24).  The  molecule  precipitated  by the  same  anti-T44  antibody  on JA3  cells 
appeared (Fig.  3B) as a diffuse band of Mr 40-45 K under reducing conditions. 
In addition,  a second band of 80-85  K could be seen.  Moreover, under nonre- MORETTA  ET  AL.  829 
FIGURE 3.  Analysis  of T44 molecule by SDS-PAGE under reducing or nonreducing condi- 
tions. JA3 cells were surface labeled with  I and lysed  as described in Materials  and Methods. 
Cell lysates were immunoprecipitated with mAb and protein  A-Sepharose. SDS-PAGE was 
performed under reducing (A-C)  and nonreducing (D-E) conditions in an 11% polyacrylamide 
gel followed by autoradiography. The internal molecular weight markers were lysozyme  (14.3 
K), carbonic  anhydrase  (30  K), ovalbumin (46  K), bovine  serum  albumine  (69  K),  and 
pbosphorylase b (92.5 K). (B and D) T44 molecules under reducing and nonreducing condi- 
tions, respectively. T3 (A) and T11 (C) molecules are shown for comparison (reduced). Anti- 
Tac, which does not precipitate any detectable material (E), was used as a negative control. 
ducing  conditions (Fig.  3D),  the  majority of the  immunoprecipitated  material 
displayed an  M,  of 80-85  K,  and  the  40-45  K  band  was  greatly decreased  in 
intensity. Thus,  the apparent Mr under both reducing and  nonreducing condi- 
tions appeared  similar  to those of the receptor molecules precipitated by anti- 
clonotypic antibody fromJA3 cells (see Fig. 5). Similar results have been recently 
obtained on 9.3 immunoprecipitates from the HPB-ALL cell line (39). 
Comparison  Between Activation Induced by Anti-T44 Antibody and that Elicited  by 
PHA or Antibodies to T3 or JTi in JA3 Cells.  The availability of the T44  + JA3 
cells and of anti-JTi clonotypic antibodies capable of inducing IL-2 production 
from these cells made it possible to analyze the response of  JA3 cells to a  variety 
of  stimuli, such as PHA and antibodies directed against T44, T3, or Ti molecules. 
As shown in Table I, PHA and antibodies to T3, JTi, or T44 molecules induced 
production of large amounts of IL-2 in the presence of PMA. Antibodies directed 
against  other  antigens  expressed  by JA3  such  as  3A1  and  4F2  (30),  used  as 
controls,  had  no  stimulatory  effect.  Although  not shown,  similar  results  were 
obtained  in  the  presence of adherent  cells without  the addition  of PMA.  It  is 
noteworthy that lower but significant IL-2 production fromJA3 was also detected 
with anti-T44 mAb in the absence of both PMA and adherent cells, whereas no 
proliferative response by resting T  cells was observed under the same conditions. 
Independent  Expression  of T44 Molecules  and  T3-Ti Receptor  Complex  at the  T 
Cell  Surface.  T44  molecules display  an  Mr  similar  to  that  of T  cell  receptor 
ino~ecules under both reducing and nonreducing conditions. This, together with 
the common ability of the two structures to trigger T  cell proliferation and IL- 
2 release, suggested a possible molecular relationship between the two molecules. 830  ANTIGEN-INDEPENDENT  PATHWAY  OF  T  CELL  ACTIVATION 
TABLE  I 
Anti-T44 mAb Induces IL-2 Production from JA3 Cells 
Stimulus  Specificity  Ig subclass 
IL-2 activity 
+PMA*  -PMA 
U/ml 
PHA  --  --  100  4 
Leu 4  T3  lgG1  124  2 
UCHT1  T3  IgG1  117  2 
9.3  T44  IgG2a  108  48 
4F2  4F2  IgG2a  5  4 
JTil  Ti  IgG2a  113  10 
JTi4  Ti  lgG2b  131  15 
3A1  3A1  IgG1  3  1 
JA3 cells (1.5  ×  105/well)  were cultured in the presence of the indicated 
stimulus for 24 h. The IL-2 activity in culture supernatants was assessed 
as described in Materials and Methods. Similar results were obtained in 
eight additional experiments. 
* PMA was added at 10 ng/ml final dilution. 
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FIGURE 4.  Modulation (or lack thereof) of T44,  T3, and Ti molecules on JA3 cell surface 
after preincubation  with mAb. JA3 cells were incubated with anti-T3, anti-T44,  or anti-JTi 
mAb for 24  h at 37°C, and subsequently washed several times. Cells incubated with one or 
another antibody were either stained directly with the anti-mouse Ig fluorescent reagent or 
incubated  (30  rain)  with  the same or one of the other antibodies  before staining with  the 
second reagent and FACS analysis.  Background fluorescence is given for cells stained with the 
fluoresceinated anti-mouse Ig reagent only. 
Antibodies  directed  to  the T3  or Ti  structures  have  been  shown  (13)  to  induce 
modulation  of the  corresponding  molecules.  In  addition,  modulation  of either 
one  of the  two  molecules  resulted  in  comodulation  of the  other.  In  agreement 
with  these  data,  anti-T3  or  anti-JTi  mAb  induced  complete  modulation  of T3- 
Ti molecular  complex  in JA3  cells (Fig. 4). Given the ability of anti-T44  antibody 
to  induce  IL-2  production  in  a  similar  manner  as anti-T3  or  anti-JTi  antibody, MORETTA  ET  AL.  831 
we  wanted  to  determine  whether  anti-T44  mAb  could  induce  modulation  of 
T44 molecules and whether a physical link existed between T44 molecules and 
the T3-Ti  molecular complex. To this end, JA3 cells were incubated for 24 h 
with  antibodies  to  T3,  JTi,  or  to  T44  (to  induce  antigen  modulation)  and 
subsequently stained with each other antibody. Although anti-T44 did not induce 
a  complete  modulation  of the  corresponding  molecules in JA3  cells,  a  strong 
reduction (-80%) of the T44 expression was observed (Fig. 4). T3-Ti expression 
was unchanged after modulation of the T44 molecules. Conversely, as previously 
shown (40),  the expression of T44 was unaffected by modulation of the T3-Ti 
complex.  In  these  experiments  we  also  investigated  the  physical  relationship 
between  T44  and  T11  molecules,  in  view  of the  involvement  of both  these 
structures in T  cell proliferation  and  lymphokine release.  In agreement  with a 
previous report (21 ), expression oft  11 molecules was not affected by modulation 
of the T3-Ti  complex;  moreover,  it remained  unchanged  after modulation  of 
T44 molecules, indicating that T11 and T44 molecules are not physically linked 
on the T  cell surface (data not shown). 
Given the susceptibility of T44 molecules to antibody-induced modulation and 
given the functional consequences of T44 triggering,  it was important to deter- 
mine  whether  T44  molecules were reexpressed  at  the  cell  surface soon  after 
modulation or whether, similarly to T3-Ti complex, reexpression occurred after 
a 48-72 h interval. To this end,JA3 cells were incubated for 24 h with antibodies 
to T44, T3, or JTi molecules, washed extensively, and cultured in the absence 
of antibody, before analysis of antigen reexpression at different culture intervals. 
Neither T3-Ti complex nor T44 were reexpressed during the first 48 h, (i. e., 
T3 and Ti were undetectable whereas T44 was still reduced by ~80%) as assessed 
by indirect  immunofluorescence  and  FACS  analysis.  T44  started  to  be  reex- 
pressed  at  72  h  and  the  reexpression  was  complete  at  96  h.  Interestingly, 
reexpression  of T44  at  the JA3  cell  surface  paralleled  that  of T3  and  JTi 
molecules. 
To further document that T44 and JTi molecules were neither identical nor 
physically related, sequential immunoprecipitation experiments were performed. 
JA3 ceils were surface labeled using lactoperoxidase-catalyzed iodination.  After 
detergent  lysis,  cell  extracts  were  immunoprecipitated  and  analyzed  by SDS- 
PAGE. Under reducing conditions (Fig. 5), the anti-T44-specific immunoprecip- 
itate consisted of M,. 44 K molecules migrating as a broad band (Fig. 5 a). Under 
the same conditions, the anti-JTi-specific immunoprecipitate  showed three dis- 
tinct bands of M, 49, 45, and 40  K, respectively (Fig.  5b).  Under nonreducing 
conditions,  the  molecules recognized by anti-T44  and anti-JTi4  mAb consisted 
of  a  similar  85  K  band  (data  not  shown).  Preclearing  of  anti-T44-specific 
molecules virtually eliminated the reactivity of such antibody for 125I-labeledJA3 
cell lysates (Fig. 5 d) but did not affect at all the reactivity of anti-JTi4 mAb (Fig. 
5 c). It must be stressed that absorption experiments using the anti-T44 antibody 
were performed using twice as much cell lysate with respect to the immunopre- 
cipitations shown in  lanes a  and b.  In addition,  preclearing  of anti-JTi-specific 
molecules abrogated the reactivity of anti-JTi antibodies for ~25I-labeledJA3 cell 
lysates but had no effect on the immunoprecipitation  of anti-T44  mAb-reactive 
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FIGURE 5.  Sequential  precipitation of  JA3 surface antigens identified byJTi4 and 9.3 mAb. 
JA3 cells were surface-labeled with z~sI and lysed as described in Materials and Methods. The 
cell lysates were immunoprecipitated  with mAb and protein  A-Sepharose.  SDS-PAGE was 
performed under reducing conditions in an 11% polyacrylamide slab gel system. The following 
molecular weight markers were used: lysozyme  (14.3 K), carbonic anhydrase (30 K), ovalbumin 
(46 K), bovine serum albumin (69 K), and phosphorylase b (92.5 K). Specific immunoprecipi- 
tares  were  obtained  by  using: (a) anti-T44  mAb,  (b) anti-Ti  mAb,  (c) anti-Ti  mAb after 
preclearing of the anti-T44-reactive popttlation, (d) anti-T44  mAb after preclearing with the 
same mAb, (e) negative control consisting of cell lysate reacted with the anti-TAC mAb. In c 
and d, twice as much cell lysate was used compared with a and b. 
T44  Triggering  of IL-2  Production  Is  Regulated  by  the  T3-Ti  Receptor  Com- 
plex.  Since  both  T44  and  T3-Ti receptor complex triggered  IL-2 production 
and, moreover, both structures were susceptible to antibody-induced modulation, 
it was important to determine whether the capacity to trigger via one structure 
was  dependent  on  the  other.  To  determine  whether  anti-T3  or  anti-JTi  anti- 
bodies  affected  subsequent  activation  by  anti-T44  antibody,  and,  conversely, 
whether anti-T44 modulation had any effect on subsequent triggering with anti- 
T3 or anti-Ti antibodies, JA3 cells were incubated for 24 b  at 37°C with one or 
another mAb, washed to remove excess antibody, and stimulated with appropri- 
ate  concentrations  of the  various  antibodies  and  PMA.  As  shown  in  Table  II, 
preincubation  of JA3  cells  with  anti-T44  antibody  virtually  abrogated  IL-2 
production  induced  by  the  same  antibody,  but  did  not  affect the  anti-T3-  or 
anti-Ti-triggered  IL-2  production.  In  contrast,  preincubation  with  anti-T3  or 
anti-JTi  mAb  abrogated  IL-2  production  triggered  by  the  same  antibodies  as 
well  as  by  anti-T44.  Similar  results  were  obtained  in  experiments  in  which 
adherent  cells (and  not  PMA)  were added  to the  cultures.  Similar  experiments 
designed to analyze the functional consequences of antibody-induced modulation 
on  IL-2 production  were performed with  purified  (resting)  peripheral  blood T 
cells.  Cells  were  preincubated  for 48  h  with  either  anti-T44,  anti-T3,  or anti- 
T  11  antibody.  After extensive washings and  FACS analysis, cells were cultured 
in the presence of one of the antibodies and adherent ceils (104/well).  The 48-b 
supernatants were assessed for IL-2 activity in  the CTL indicator system. Prein- 
cubation  of  T  cells  with  anti-T44  antibody  abrogated  the  IL-2  production 
induced  by  the  same  antibody  but  had  no  effect  on  anti-T3-mediated  IL-2 
production.  In contrast,  preincubation  with anti-T3 antibody abrogated the IL- 
2 production triggered by anti-T3 or anti-T44 antibody. The anti-T11  antibody MORETTA  ET  AL.  833 
TABLE 1I 
Influence  of mAb-induced Modulation on JA3 Activation by 
Anti-T44 mAb 
JA3 cell 
Stimulus* 
Anti-T3  Anti-Ti*  Anti-T44  Anti-T11 
Unmodulated  113  138  119  1  2 
T3 modulated  68  11  9  5  2 
Ti modulated  19  3  5  3  3 
T44 modulated  118  127  2  2  3 
T11  modulated  124  133  128  8  2 
JA3 cells were incubated for 24 h with one or another mAb as described 
in  Materials and  Methods,  washed, and subsequently seeded at  1.5  x 
105/well  in  the  presence  of the  various  mAb and  PMA  (10  ng/ml). 
Supernatants  were  collected  24  h  later  and tested  for  IL-2  activity as 
described in Materials and Methods. 
*  PMA was added to all cultures. 
* Anti-JTi4 antibody was added. 
Values indicate the arbitrary units of IL-2 per ml. 
used as control neither induced modulation of the corresponding molecules nor 
promoted any detectable IL-2 production by T cells (not shown). Thus, it appears 
that modulation of the T3-Ti receptor complex, although having no effect on 
T44 expression at the cell surface, regulated the ability of the T44 structure to 
induce IL-2 release. 
Discussion 
In  the present  report  we describe a  new pathway of human T  lymphocyte 
activation triggered by the T  cell lineage-specific T44  surface molecule after 
binding to a  specific mAb.  Some physical and functional characteristics of the 
T44  molecules  appeared  similar  to  those  of the  T  cell  receptor  molecules, 
including comparable  Mr  under  both  reducing  and  nonreducing conditions, 
susceptibility to antibody-induced modulation, and the capability of triggering T 
lymphocyte proliferation and IL-2 release. A possibility was that anti-T44 anti- 
body recognized a monomorphic determinant of the T  cell receptor. However, 
our  present  data  provide  clear  evidence  that  the  two  surface  structures  are 
physically independent. Moreover, we show that T44 molecules are not physically 
related to the T 11 structure, which is also capable of mediating a T cell activation 
alternative to that initiated by the T3-Ti receptor complex (21). 
The T44 molecule was expressed in both resting and activated T  lymphocytes 
and in some T  celt ieukemias (23),  while it was weakly expressed on a subpopu- 
lation of thymocytes. In this respect, distribution of T44 molecules differs from 
that of the M, 50 K T11  or the 40 K 3A1  molecules, which are present on 98% 
of thymocytes and thus represent early T  cell differentiation antigens. In addi- 
tion, according to Hansen et al. (23),  distribution of the T44 molecules could be 
distinguished from that of T3 antigen on the basis of differential reactivity with 
some T  cell leukemias. 
Similar to anti-T3 or anti-T11, anti-T44 antibody induced both T  cell prolif- 
eration and IL-2 release. However, whereas T 11 triggering in resting T  lympho- 834  ANTIGEN-INDEPENDENT  PATHWAY  OF  T  CELL  ACTIVATION 
cytes could be achieved with  antibody in  soluble form (21),  triggering  of T44 
molecule, like that of T3, required the presence of adherent cells. On the other 
hand, triggering of  JA3 cells could be achieved with anti-T44 in absence of PMA 
or adherent cells, while triggering of  JA3 with either anti-T3 or anti-Ti antibody 
required  PMA or adherent  cells.  In  a  previous report (25) the same anti-T44 
antibody did not induce proliferation of resting T  cells. A likely explanation for 
this discrepancy may be that, in contrast to lymphocyte suspensions used in our 
study,  lymphocytes  were  nylon  wool-passed  and  therefore  depleted  of most 
adherent cells. 
We  also  studied  the  relationships  between  T44  molecules  and  the  other 
monomorphic or clonotypic structures involved in T  cell activation, on the JA3 
tumor T  cell line. JA3 appeared  to be particularly  suitable for these studies in 
view of its ability to produce large amounts of IL-2 after appropriate stimuli and 
because mAb to the JA3 clonotypic structures were available. Antibody-induced 
antigen modulation experiments showed that T44 molecules, like T3 or Ti, were 
susceptible to modulation.  However, while modulation  of T3  or Ti  molecules 
resulted  in  reciprocal  comodulation,  it  had  no  effect on  T44  surface antigen 
expression.  Moreover, modulation  of T44  molecules had  no effect on T3,  Ti, 
or T11  antigen  expression.  These experiments,  together with  the finding that 
preclearing  125I-labeled  JA3  lysates  with  anti-T44  did  not  remove  molecules 
immunoprecipitated by anti-Ti antibodies, and that preclearing with anti-JTi did 
not  remove  molecules  reactive  with  anti-T44  mAb,  indicate  that  the  T44 
molecule is not identical and probably not physically related to the 0e or/3 chains 
of the T cell receptor. The T cell receptor complex, however, appears to regulate 
the  capacity of the  pathway of T  cell  activation  initiated  by T44  molecule to 
induce  T  cell  responses.  This  conclusion  is  based  on  the  observation  that 
modulation of T3 or Ti molecules leads to inhibition  of T  cell response to anti- 
T44 antibody. A similar dependency upon the T3-Ti antigen receptor complex 
has been described by Meuer et al.  (21) for the T11-dependent  pathway of T 
cell activation.  Study of the functional  correlation  between these two antigen- 
independent pathways of T  cell activation could not be carried out because anti- 
Tll  mAb  with  stimulatory  capacity  were  not  available  in  our  lab;  however, 
modulation experiments indicated that T44 and T11  molecules were not physi- 
cally linked at the cell surface. 
The T44 pathway of T  cell activation  may be triggered by a  still  undefined 
natural  ligand.  It  cannot  be  excluded  that  the  T44  molecule  itself  may  be 
important  for cell-to-cell  contacts,  as suggested by preliminary  experiments  in 
which anti-T44  antibody had a  strong inhibitory activity on specific target  cell 
lysis mediated by alloreactive cytolytic cells. Whatever the natural ligand of T44 
molecule may be, the late reexpression of this molecule after antibody-induced 
modulation  is strikingly similar to that  of the T3-Ti antigen  receptor complex. 
This  latency  will  likely be  important  for  the  regulation  of the  T44-triggered 
pathway  of T  cell  activation.  Future  studies  characterizing  the  relationship  of 
the  T3-Ti  antigen  receptor  complex  and  the  T44  molecule,  by the  study  of 
T44- mutants of JA3 similar to the Ti- mutants described by Weiss and  Stobo 
(6),  should  better  define  the  relative  function  and  behavior  of these  surface 
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Summary 
Prior studies indicate that  the 9.3 monoclonal antibody (mAb) which defines 
a  44  kD  T  lineage-specific  glycoprotein  (T44)  enhances  the  proliferative  re- 
sponse  of peripheral  blood  T  lymphocytes  to  phytohemagglutinin  (PHA)  or 
allogeneic cells. The T44 molecule was expressed in both resting and activated 
T  lymphocytes and in a subset of thymocytes, as assessed by indirect immunoflu- 
orescence and flow cytofluorometry. In view of the potential importance of T44 
in T  cell activation, we investigated the ability of the 9.3 (anti-T44) antibody to 
stimulate peripheral  blood T  lymphocytes under culture conditions giving opti- 
mal proliferative  responses to anti-T3  mAb.  Like UCHT1  (anti-T3)  mAb, the 
9.3 (anti-T44  mAb) promoted strong proliferative responses of purified T  cells, 
provided that  adherent  cells were added to the culture.  Maximal  proliferation 
in response to 9.3 antibody was consistently detected at day 5 (at day 3 with anti- 
T3 or PHA). Moreover, triggering  of T  lymphocytes with 9.3 antibody (in  the 
presence of adherent cells) resulted in strong IL-2 production that peaked at 48 
h. Analysis of the physical and functional relationship between the T44 molecule 
and  other  molecules involved in  T  cell activation,  including  the clonotypically 
restricted Ti and the monomorphic T3 or T11  molecules, was carried out on a 
mutagenized  Jurkat  T  leukemia  cell  line.  This  mutant,  termed JA3  (surface 
phenotype:  T11 +,  T3 +,  3A1 +,  T4-,  T8-,  DR-,  Tac-,  4F2 +,  T44 +)  produced 
large  amounts  of IL-2  upon  stimulation  with  PHA, anti-T3,  or anticionotypic 
mAb  in  conjunction  with  phorbol  myristate  acetate  (or  adherent  cells).  The 
molecules precipitated by anti-T44  mAb from 125I-labeled JA3 cells appeared as 
a diffuse band of Mr 40-45,000 under reducing conditions; under nonreducing 
conditions, a prominent band of Mr 80-85,000 was observed, while the Mr 40- 
45,000  band  was greatly reduced.  Thus,  T44  molecules in  both reducing and 
nonreducing conditions had relative molecular weights similar to that of mole- 
cules carrying clonotypic (Ti) determinants.  In addition,  like anti-Ti or anti-T3 
mAb, anti-T44 antibody induced JA3 cells to produce large amounts of IL-2 in 
the presence of phorbol  myristate acetate.  Other  similarities between T44 and 
molecules carrying clonotypic structures included the susceptibility to antibody- 
induced  modulation  and  the  late  reexpression  (72  h)  at  the  cell  surface after 
modulation.  Taken  together,  these  experiments  suggest  that  anti-T44  mAb 
might recognize a monomorphic determinant of the T  cell receptor molecule or 
be physically or functionally linked to the T3-Ti  complex.  However, antibody- 
induced modulation ofT44 molecules did not lead to the loss ofT3, Ti, or T11 
molecules, nor did modulation of T3 or Ti affect the expression of T44 antigen 
at the JA3 cell surface. In addition, sequential immunoprecipitation experiments 
showed  that  preclearing  of JA3  cell  lysates  with  anti-T44  antibody  did  not 
remove  molecules  carrying  clonotypic  structures,  and  that  preclearing  with 
anticlonotypic mAb did not affect subsequent precipitation  with anti-T44  mAb. 
Thus,  the  antigen-independent,  T44-mediated  mode  of T  cell  triggering  is 
distinct  from that  initiated  by the T3-Ti  antigen  receptor complex or by T11 
molecules.  However,  modulation  of the  T3-Ti  receptor  complex,  although  it 
had  no effect on  T44 expression,  did regulate  the ability of T44  molecules to 
induce IL-2 release. The nature of the natural  ligand of T44 molecule and the 836  ANTIGEN-INDEPENDENT PATHWAY OF  T  CELL  ACTIVATION 
role in vivo of T44-triggered  pathway of human  T  cell activation  remains  to be 
determined. 
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